Transit Met Chem
Preparation of complex 1d
6.99–7.83 (m, 24H, Ar–H). 13C NMR (75.47 MHz, DMSO-
d6) δ (ppm) = 21.3 (–CH2C6H4(CH3)); 29.0 (–(C6H4)NCH-
2CH2CH2N); 36.3 (–(C6H4)NCH2CH2CH2N); 46.3 (–(C6H4)
NCH2CH2CH2N); 52.7 (–CH2C6H4(CH3)); 110.2, 111.4,
123.1, 124.7, 124.9, 128.4, 128.7, 132.1, 133.9, 134.2,
134.3, 134.5, 135.4, 135.6, 138.3 and 138.6 (Ar–C); 168.2
(C=O); 182.1(2–C–Pd).
According to the same procedure as for complex 1a, com-
plex 1d was prepared from bromo[1-(2-methoxyethyl)-
3-(N-propylphthalimide)benzimidazol-2-ylidene]silver(I)
(287 mg. 0.52 mmol). Yield: 0.19 g (75%). Anal. Calc.
for C42H42N6O6PdBr2: C: 50.80, H: 4.26, N: 8.46. Found:
1
C: 50.73, H: 5.22, N: 8.42. H NMR (300 MHz, DMSO-
d6) δ (ppm) = 3.26 (s, 6H, –CH2CH2OCH3); 3.90 (m, 4H,
–CH2CH2OCH3); 4.97 (m, 4H, –CH2CH2OCH3); 2.51
(m, 4H, –(C6H4)NCH2CH2CH2N); 4.26 (m, 4H, –(C6H4)
NCH2CH2CH2N); 4.99 (m, 4H, –(C6H4)NCH2CH2CH2N);
7.37–7.91 (m, 16H, Ar–H).13C NMR (75.47 MHz, DMSO-
d6) δ (ppm) = 29.4 (–(C6H4)NCH2CH2CH2N); 35.2
(–(C6H4)NCH2CH2CH2N); 56.6 (–(C6H4)NCH2CH2CH2N);
29.1 (–CH2CH2OCH3); 36.2 (–CH2CH2OCH3); 58.9
(–CH2CH2OCH3); 123.4, 123.5, 132.2, 132.3, 134.7 and
134.8 (Ar–C); 181.9 (2–C–Pd).
Preparation of complex 1g
According to the same procedure as for complex 1a, com-
plex 1g was prepared from chloro[1-(4-methylbenzyl)-
3-(N-propylphthalimide)benzimidazol-2-ylidene]silver(I)
(288 mg. 0.52 mmol). Yield: 0.20 g (78%). Anal. Calc. for
C52H46N6O4PdCl2: C: 62.69, H: 4.65, N: 8.44. Found: C:
62.75, H: 4.69, N: 8.48. 1H NMR (300 MHz, DMSO-d6) δ
(ppm) = 2.27 (s, 6H, –CH2C6H4(CH3)); 2.59 (m, 4H, –(C6H4)
CH2CH2CH2N–); 3.71 (t, 4H, –(C6H4)CH2CH2CH2N, J:
7.2 Hz); 4.91 (t, 4H, –(C6H4)CH2CH2CH2N–, J: 7.2 Hz);
5.96 (s, 4H, –(C6H4)CH2C6H4(CH3)); 7.02–7.86 (m, 24H,
Ar–H). 13C NMR (75.47 MHz, DMSO-d6) δ (ppm) = 21.1
(–CH2C6H4(CH3)); 28.9 (–(C6H4)CH2CH2CH2N–); 36.3
(–(C6H4)CH2CH2CH2N–); 46.1 (–(C6H4)CH2CH2CH2N–);
52.3 (–CH2C6H4(CH3)); 110.2, 110.5, 111.5, 123.0, 123.3,
127.6, 127.8, 129.3, 132.1, 132.5, 132.7, 133.9, 134.2,
134.3, 134.5, 137.3 ve 137.5 (Ar–C); 167.9 and 168.2
(C=O); 181.9 (2–C–Pd).
Preparation of complex 1e
According to the same procedure as for complex 1a,
complex 1e was prepared from bromo[1-(2-ethoxyethyl)-
3-(N-propylphthalimide)benzimidazol-2-ylidene]silver(I)
(294 mg. 0.52 mmol). Yield: 0.17 g (65%). Anal. Calc.
for C44H46N6O6PdBr2: C: 51.76, H: 4.54, N: 8.23.
1
Found: C: 51.87, H: 4.64, N: 8.27. H NMR (300 MHz,
DMSO-d6) δ (ppm) = 1.24 (t, 6H, –CH2CH2OCH2CH3,
J: 7.2 Hz); 2.64 (m 4H, –(C6H4)NCH2CH2CH2N–); 3.50
(m 4H, –CH2CH2OCH2CH3); 4.12 (m, 4H, –(C6H4)
NCH2CH2CH2N–); 4.14 (t, 4H, –CH2CH2OCH2CH3,
J: 7.2 Hz); 4.71 (m, 4H, –CH2CH2OCH2CH3); 5.15
(m, 4H, –(C6H4)NCH2CH2CH2N–); 7.28–7.91 (m,
16H, Ar–H). 13C NMR (75.47 MHz, DMSO-d6) δ
(ppm) = 15.2 (–CH2CH2OCH2CH3); 28.9 (–(C6H4)NCH-
2CH2CH2N–); 36.3 (–(C6H4)NCH2CH2CH2N–); 46.2
(–CH2CH2OCH2CH3); 66.8 (–(C6H4)NCH2CH2CH2N–);
69.8 (–CH2CH2OCH2CH3); 70.2 (–CH2CH2OCH2CH3);
109.9, 110.2, 111.6, 112.1, 123.2, 123.3, 132.1, 132.2, 133.8
and 134.1 (Ar–C); 181.6 (2–C–Pd).
Preparation of complex 1h
According to the same procedure as for complex 1a, com-
plex 1h was prepared from chloro[1-(2,4,6-trimethylbenzyl)-
3-(N-propylphthalimide)benzimidazol-2-ylidene]silver(I)
(302 mg. 0.52 mmol). Yield: 0.23 g (87%). Anal. Calc.
for C56H54N6O4PdCl2: C: 63.91, H: 5.17, N: 7.99. Found:
1
C: 64.01, H: 5.20, N: 8.04. H NMR (300 MHz, DMSO-
d6) δ (ppm) = 2.77 (m, 4H, –(C6H4)CH2CH2CH2N–);
4.16 (t, 4H, –(C6H4)CH2CH2CH2N–, J: 7.5 Hz); 5.23 (t,
4H, –(C6H4)CH2CH2CH2N–, J: 7.5 Hz); 2.27 and 2.35 (s,
18H,CH2C6H2(CH3)3); 6.18 (s, 4H, –CH2C6H2(CH3)3),
6.38–7.82 (m, 20H, Ar–H). 13C NMR (75.47 MHz, DMSO-
d6) δ (ppm) = 20.9 and 21.1 (–CH2C6H2(CH3)3); 29.0
(–(C6H4)CH2CH2CH2N); 36.3 (–(C6H4)CH2CH2CH2N);
46.3 (–(C6H4)CH2CH2CH2N); 49.6 (–CH2C6H2(CH3)3);
110.3, 111.8, 122.8, 123.2, 128.2, 129.6, 132.0, 132.2,
133.8, 134.3, 134.5, 138.2, 138.5 ve 138.9 (Ar–C); 168.1
(C=O); 182.0 (C–Pd).
Preparation of complex 1f
According to the same procedure as for complex 1a, com-
plex 1f was prepared from chloro[1-(3-methylbenzyl)-
3-(N-propylphthalimide)benzimidazol-2-ylidene]silver(I)
(288 mg. 0.52 mmol). Yield: 0.21 g (81%). Anal. Calc.
for C52H46N6O4PdCl2: C: 62.69, H: 4.65, N: 8.44. Found:
1
C: 62.65, H: 4.61, N: 8.38. H NMR (300 MHz, DMSO-
Preparation of complex 1i
d6) δ (ppm) = 2.32 (s, 6H, –CH2C6H4(CH3)); 2.81 (m,
4H, –(C6H4)NCH2CH2CH2N–); 4.19 (t, 4H, –(C6H4)
NCH2CH2CH2N, J: 7.2 Hz); 5.14 (t, 4H, –(C6H4)NCH-
2CH2CH2N, J: 7.2 Hz); 5.97 (s, 4H, –CH2C6H4(CH3));
According to the same procedure as for complex 1a, com-
plex 1i was prepared from chloro[1-naftalenomethyl-
3-(N-propylphthalimide)benzimidazol-2-ylidene] silver(I)
1 3